News

A rapid laboratory test, the eosinophil count, readily obtained from a routine complete blood cell count could aid in the early recognition of COVID-19 in patients, according to new research.

Researchers examining immune cells produced against coronaviruses have uncovered a wealth of information about how this critical aspect of immunity could fight off COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. The new study provides hope that some immune responses to SARS-CoV-2 could be long-lasting.

A new study has explored whether soil fluorine levels in New Zealand are high enough to hurt a Rhizobium, bacteria that support legume crops.

SARS-CoV-2 uses a surface spike protein to latch onto human cells and initiate infection. But, the drug heparin is capable of binding tightly to the same surface spike protein, potentially blocking the infection from happening.

Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad and her colleagues describe a newly understood way by which breast cancer cells sabotage a key player in the body’s immune system.

Biomolecular engineers have uncovered a technique that dramatically enhances the accuracy of CRISPR-based edits in disease sequence models.

In Phase 2b clinical trials, a once-daily roflumilast cream showed significant improvements in psoriasis signs and symptoms, in as early as two weeks.

A study published in Nature Communications presented evidence of transplacental transmission of SARS-CoV-2 from an infected mother to her unborn child.

A single protein derived from a common strain of bacteria found in the soil will offer scientists a more precise way to edit RNA.

Researchers have found that placental cells minimally express the instructions, or mRNA, to generate the cell entry receptor and protease required by the virus that causes COVID-19 to invade human cells.